Financial Statements — PLMR
Balance Sheet
(in billions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 | Q1
2024 | Q3
2023 | Q2
2023 | Q1
2023 | Q3
2022 | Q2
2022 | Q1
2022 | Q3
2021 | Q2
2021 | Q1
2021 |
|---|
| Cash & Equivalents | 0.06 | 0.06 | 0.11 | 0.08 | 0.12 | 0.09 | 0.05 | 0.06 | 0.05 | 0.06 | 0.08 | 0.03 | 0.04 | 0.05 | 0.04 | 0.02 | 0.02 |
| Total Assets | 3.96 | 3.61 | 2.94 | 2.83 | 2.43 | 2.28 | 2.02 | 1.88 | 1.63 | 1.55 | 1.44 | 1.22 | 1.05 | 0.96 | 0.88 | 0.83 | 0.83 |
| Long-term Debt | 0.30 | 0.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities | 2.98 | 2.65 | 2.07 | 1.99 | 1.64 | 1.57 | 1.48 | 1.38 | 1.21 | 1.13 | 1.04 | 0.85 | 0.67 | 0.58 | 0.50 | 0.45 | 0.45 |
| Retained Earnings | 0.45 | 0.44 | 0.37 | 0.35 | 0.31 | 0.23 | 0.20 | 0.17 | 0.12 | 0.11 | 0.10 | 0.08 | 0.08 | 0.07 | 0.05 | 0.05 | 0.06 |
| Total Stockholder Equity | 0.98 | 0.96 | 0.88 | 0.85 | 0.79 | 0.70 | 0.53 | 0.50 | 0.42 | 0.41 | 0.40 | 0.37 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Net Premiums Earned | 286.95 | 261.44 | 233.46 | 225.15 | 179.96 | 164.07 | 144.89 | 135.65 | 122.29 | 107.87 | 93.75 | 85.82 | 83.11 | 83.24 | 82.23 | 77.94 | 80.27 | 76.03 | 67.84 | 64.72 |
| Net Investment Income | 19.95 | 17.98 | 15.99 | 14.57 | 13.37 | 12.07 | 11.32 | 9.41 | 7.96 | 7.14 | 7.02 | 6.03 | 5.54 | 5.12 | 4.41 | 3.74 | 3.14 | 2.58 | 2.43 | 2.24 |
| Total Revenue | 314.42 | 278.94 | 253.36 | 244.66 | 203.31 | 174.63 | 155.76 | 148.50 | 131.07 | 118.54 | 105.39 | 90.94 | 90.40 | 89.20 | 88.62 | 80.69 | 79.66 | 78.11 | 73.17 | 67.66 |
| Benefits & Claims | 98.99 | 87.10 | 70.86 | 72.81 | 46.18 | 38.74 | 37.18 | 40.32 | 30.43 | 26.84 | -- | -- | -- | 20.65 | 18.42 | 30.90 | 14.40 | 14.95 | 10.17 | 28.48 |
| Total Benefits & Expenses | 244.62 | 225.48 | 180.71 | 177.52 | 143.43 | 120.92 | 110.79 | 110.00 | 97.70 | 84.18 | 71.94 | 66.40 | 67.38 | 66.57 | 63.65 | 75.49 | 61.37 | 59.03 | 51.78 | 67.54 |
| Tax Provision | 17.21 | 10.51 | 16.49 | 15.68 | 13.35 | 10.79 | 10.00 | 8.01 | 7.65 | 7.97 | 7.56 | 6.10 | 5.46 | 5.32 | 6.22 | 0.91 | 3.70 | 4.55 | 4.76 | (0.12) |
| Net Income | 52.59 | 42.95 | 56.17 | 51.46 | 46.53 | 42.92 | 34.97 | 30.50 | 25.73 | 26.38 | 25.89 | 18.43 | 17.56 | 17.31 | 18.76 | 4.29 | 14.59 | 14.54 | 16.63 | 0.25 |
| Diluted EPS | 1.94 | 1.57 | 2.05 | 1.87 | 1.68 | 1.57 | 1.29 | 1.15 | 1.00 | 1.04 | 1.03 | 0.73 | 0.69 | 0.68 | 0.72 | 0.17 | 0.57 | 0.56 | 0.65 | 0.01 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 | Q1
2024 | Q4
2023 | Q3
2023 | Q2
2023 | Q1
2023 | Q4
2022 | Q3
2022 | Q2
2022 | Q1
2022 | Q4
2021 | Q3
2021 |
|---|
| Operating Cash Flow | 167.17 | 47.03 | 117.42 | 83.64 | 120.88 | 87.18 | 72.64 | 100.27 | 55.13 | 33.13 | 22.27 | 70.63 | 5.77 | 17.44 | 75.04 | 11.75 | 35.00 | 47.80 | 54.40 | 42.77 |
| Capital Expenditures | 0.42 | 0.00 | 0.02 | 0.05 | 0.03 | 0.04 | 0.05 | 0.19 | 0.00 | -- | 0.00 | -0.00 | 0.02 | -- | 0.01 | 0.04 | 0.26 | 0.01 | 0.00 | 0.00 |
| Free Cash Flow* | 166.76 | 47.03 | 117.39 | 83.59 | 120.85 | 87.15 | 72.59 | 100.07 | 55.13 | -- | 22.27 | 70.64 | 5.75 | -- | 75.03 | 11.71 | 34.74 | 47.79 | 54.40 | 42.77 |
| Investing Cash Flow | (119.73) | (373.38) | (123.55) | (17.74) | (160.75) | (51.94) | (81.36) | (179.88) | (28.67) | (16.33) | (24.32) | (51.25) | (19.01) | (33.90) | (35.38) | (19.92) | (47.87) | (53.63) | (45.99) | (27.67) |
| Financing Cash Flow | (41.30) | 276.02 | 1.26 | (35.46) | 1.86 | 3.55 | 2.68 | 118.18 | (40.20) | (6.88) | 0.62 | (24.70) | (8.51) | 28.66 | (1.03) | 1.22 | 2.44 | 2.40 | 0.34 | 0.92 |
* Derived from reported values
